Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Dementia cases in the U.S. are expected to double by 2060, with an estimated one million people diagnosed per year, according ...

The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...

LEXINGTON Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are at the forefront of advancing ...